Acne News

• Updated Rosacea Treatment Algorithms Available Aimed at addressing systemic inflammation, National Rosacea Society treatment algorithms take a phenotype-driven approach wherein signs and symptoms guide diagnosis and treatment choices.
  Medscape Medical News, April 08, 2025
• Isotretinoin: Risks Beyond Depression, Suicidality Evaluated The study evaluates 20 years of the US Food and Drug Administration (FDA) Adverse Event Reporting System data.
  Medscape Medical News, March 24, 2025
• Real-World Study Reveals Early Success of Upadacitinib in AD Upadacitinib demonstrates early and sustained effectiveness up to 1 year in patients with moderate to severe atopic dermatitis in a real-world study.
  Medscape News UK, March 20, 2025
• FDA Confirms Low Benzene Levels in Most BPO Products Tested Certain manufacturers, however, have voluntarily recalled products in the wake of FDA testing.
  Medscape Medical News, March 18, 2025
• Remote Infections Raise Risk for Surgical Site Infection Ongoing remote infections nearly double the risk for surgical site infections in intracranial neurosurgery procedures.
  Medscape News UK, March 17, 2025
• Upadacitinib Shows Efficacy in Refractory Crohn's Disease Upadacitinib induction therapy provides steroid-free clinical remission in over 50% of patients with Crohn's disease who do not respond to conventional treatment and has an acceptable safety profile.
  Medscape News UK, March 12, 2025
• Can Smokers Safely Use Upadacitinib for Atopic Dermatitis? Upadacitinib is potentially safe and effective for patients with moderate to severe atopic dermatitis, irrespective of smoking status.
  Medscape News UK, March 06, 2025
• At-Home LED Devices Reduce Acne Lesions in Meta-Analysis A systematic review finds that red and blue light-emitting diode (LED) devices significantly reduce acne lesions with minimal side effects.
  Medscape Medical News, March 05, 2025
• Rosacea: Newer Approaches to Diagnosis, Management Natural compounds are on the menu, while heparan sulfate analogs may be coming.
  Medscape Medical News, March 03, 2025
• Benzene in Benzoyl Peroxide Products: New Findings A new analysis of BP products and benzene degradation finds that formulation matters, with leave-on products having lower benzene, and levels ‘unlikely to be a clinically meaningful issue,’ a researcher said.
  Medscape Medical News, February 21, 2025
• Most Spironolactone TikTok Videos Lack Reliability, Quality A review showed that patient testimonials dominate TikTok videos on spironolactone for acne treatment and are of poor reliability and quality.
  Medscape Medical News, February 07, 2025
• What to Make of the Comorbidities Linked to Rosacea Recent studies support associations between rosacea and dyslipidemia, gastrointestinal issues, and depression, which “seem to come up most frequently,” said Gallo.
  Medscape Medical News, January 23, 2025
• MauiDerm 2025 Heritability Strongly Linked to Acne Fulminans “There is in fact a greater than 3-fold risk with affected first-degrees family members,” Dr. Dawn Eichefield said.
  Medscape Medical News, January 21, 2025
• Study Finds Medicaid Coverage Gaps in Rosacea Treatments A study highlighted significant discrepancies in Medicaid state formularies for rosacea, with only a few states offering unrestricted access to essential treatments.
  Medscape Medical News, January 20, 2025
• Study Examines Acne Relapse and Isotretinoin Retrial The study cohort included 19,907 patients with acne, with a mean age of 20.6 years.
  Medscape Medical News, January 17, 2025
• CO2 Laser Improves Postburn Scar Healing in Skin of Color Fractional CO2 laser therapy improved mature hypertrophic burn scars, reducing vascularity, pigmentation, and pliability issues, with promising results for skin of color, in a small study.
  Medscape Medical News, January 16, 2025
• Survey Outlines Pediatric Cosmetic Dermatology Trends A national survey highlighted scars, acne, and hyperhidrosis as the most commonly treated pediatric cosmetic conditions, with lasers leading as the most common treatment approach.
  Medscape Medical News, December 16, 2024
• LGBTQ+-Inclusive Language Missing in Acne Assessment An analysis of patient-reported outcome measures used for acne revealed gaps in the use of LGBTQ+-inclusive language, highlighting barriers to equitable care and assessment.
  Medscape Medical News, December 06, 2024
• SDPA 2024 Expert Discusses the ‘Four Pillars of Acne Pathogenesis’ “The average number of acne products used per patient is 2.53, but that’s also the average number of copays,” Shanna Miranti said.
  Medscape Medical News, December 03, 2024
• SDPA 2024 How to Calm Rosacea-Related Facial Erythema, Flushing Brimonidine 0.33% gel and oxymetazoline 1% cream typically start working within 30-60 minutes, according to Julie C. Harper.
  Medscape Medical News, November 22, 2024